Medicines - Gilead Sciences
WEBAccess the list of approved Gilead therapies across virology including HIV, liver disease including hepatitis and primary biliary cholangitis, oncology & inflammation. ... The content on this page contains information about Gilead products and is intended for audiences in the United States. If you are a resident of the United States, please ...
Gilead Sciences: Innovative Virology Research & Therapies
WEBLeading and. Innovating in Virology. As a leader and pioneer in antiviral development, we helped transform HIV from a fatal illness to a preventable chronic condition. We introduced the first HIV single tablet treatment regimen and continue to improve safety, convenience and efficacy in treatment and prevention options.
Gilead Sciences: Innovative HIV Prevention and Treatment
WEBGoing Beyond the Medicine. Our extensive early research and development program is the foundation of our efforts to help end the HIV epidemic. Our scientists are dedicated to discovering the next generation of medical breakthroughs, including alternate dosing schedules and routes of administration, to improve the lives of people impacted.
Gilead Sciences: Prioritizing Patient Safety
WEBOur Approach to Patient Safety. Since Gilead was founded over 35 years ago, our work has improved the health of millions of people worldwide. Our dedication to provide safe and effective medicines starts in the research laboratory and extends through the entire life cycle of our products. Quality plays an integral role in the foundation of our ...
Gilead Sciences
WEBFor more than 35 years, we have been tackling some of the world’s greatest public health challenges, revolutionizing HIV treatment and prevention and delivering a cure for hepatitis C.
Gilead Sciences - Wikipedia
WEBGilead Sciences, Inc. (/ ˈ ɡ ɪ l i ə d /) is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.
Gilead Sciences’ Approach to Research & Drug Discovery
WEBWe foster a collaborative, curious and creative culture rooted in scientific exploration. Gilead researchers are empowered to pursue extraordinary discoveries and make a transformative impact on the world. Powered by innovation, our R&D teams are driven to generate advances in drug discovery, out-innovate current therapeutics and help patients ...
Gilead’s Twice-Yearly Lenacapavir Demonstrated 100% Efficacy …
WEBJun 20, 2024 · PURPOSE 1 met its key efficacy endpoints of superiority of twice-yearly lenacapavir to once-daily oral Truvada ® (emtricitabine 200mg and tenofovir disoproxil fumarate 300mg; F/TDF) and background...
Virology, Inflammation, & Oncology Pipeline | Gilead - Gilead Sciences
WEBAug 8, 2024 · We have a strong and diverse pipeline and are on track to achieve our ambition, set in 2019, of delivering 10+ transformative therapies by 2030. Through pioneering science and innovative partnerships, we’ll continue to expand our research and development programs to take on pressing unmet needs in …
Our Medications │ Gilead Medical Information
WEBOur Medications. Please refer to each medication’s prescribing information and medication guide or patient information for specific details. To report an adverse event, please call 1‑800‑445‑3235 (option #3) 24 hours/day, 7 days/week. Explore …